Search

Displaying results 4841 - 4850 of 10000 in total
  1. Drug

    Pimobendan

    go.drugbank.com/drugs/DB11450
    ExperimentalVet approved

    Synonyms: dl-PimobendanCategories: Compounds used in a research, industrial, or household setting
  2. Drug

    Ammonium tetrathiomolybdate

    go.drugbank.com/drugs/DB17641
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Tricetin

    go.drugbank.com/drugs/DB08230
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Dovitinib

    go.drugbank.com/drugs/DB05928
    Investigational

    Chiron currently has three ongoing Phase I clinical trials for dovitinib. … Dovitinib is an orally active small molecule that exhibits potent inhibitory activity against multiple RTKs involved in tumor growth and angiogenesis.

  5. Drug

    Acetate

    go.drugbank.com/drugs/DB14511
    Investigational

    Synonyms: Acetate ion, Acetoxy ionMixtures: VAMIN 14 IV AMINOASIT SOLÜSYONU, 500 ML, NUTRIFLEX LIPID PERI INFUZYONLUK IV EMULSIYON, 2500 ML
  6. Drug

    19-norandrostenedione

    go.drugbank.com/drugs/DB01434
    ExperimentalIllicit

    After 2005, 19-Norandrostenedione was regulated in the United States as a schedule III controlled substance, as well as banned from use in competitive sports by the World Anti-Doping Agency. … In the body 19-norandrostenedione is rapidly metabolized into [nandrolone], also known as nortestosterone.

  7. Drug

    Meclofenoxate

    go.drugbank.com/drugs/DB13758
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  8. Drug

    AT1391

    go.drugbank.com/drugs/DB05120
    Experimental

    AT1391 is a daily insulin skin patch designed to provide continuous basal levels of insulin for patients with diabetes.

  9. Drug

    PPI-1019

    go.drugbank.com/drugs/DB05832
    Investigational

    Apan (PPI-1019) is developed by Praecis Pharmaceuticals to treat Alzheimer's Disease.

  10. Drug

    R673

    go.drugbank.com/drugs/DB05466
    Experimental

    The phase II program for treatment of depression and anxiety is ongoing in the US and EU.It is not clear how tachykinin antagonists exert their effect, but SP levels have been commonly linked to the functioning … R673 is a novel NK1 antagonist that penetrates the blood-brain barrier, has excellent safety and tolerability and shows low P450-based drug interaction potential.